Suki Ambient AI Notes Now Generally Available to All athenahealth Network Users. by Fred Pennic 05/01/2025 Leave a Comment. Source: Suki AIWhat You Should Know: – Suki, a leader in AI technology for healthcare, announced the general availability of its ambient technology to all health systems within athenahealth’s network through athenahealth’s integrated Ambient Notes solution. This significant milestone expands a longstanding partnership of over seven years between Suki and athenahealth, a prominent provider of network-enabled software and services for healthcare organizations nationwide.– The general release follows a highly successful beta phase where clinicians utilized Suki’s ambient technology via Ambient Notes in over 60,000 patient encounters, demonstrating strong adoption and user engagement.Seamless Integration into Clinician WorkflowThis deepened technology integration means all athenahealth users now have the option to leverage Suki’s AI capabilities directly within their existing athenaOne mobile app workflow. This eliminates the need for separate applications and provides a more seamless user experience compared to the previous Suki Assistant offering available through the athenahealth Marketplace.The original Suki Assistant integration saw over 2,000 clinicians utilize the tool across more than 2 million clinical encounters, highlighting Suki’s established presence within the athenahealth ecosystem.Proven Benefits for CliniciansClinicians using Suki’s ambient technology report significant reductions in administrative burden and improvements in work-life balance.“In my primary care practice, I was used to spending 4-6 hours on my weekend completing documentation on top of a 50+ hour work week. Now using Suki’s ambient listening capabilities through Ambient Notes, I haven’t gone to the clinic on a single weekend and am close to 90-100 percent same-day note completion,” shared Dr

Johnson & Johnson reportedly found that 10% to 15% of artificial intelligence use cases deliver 80% of the value.The medicine and MedTech company determined that after encouraging employees to experiment with AI and, after about three years, seeing the results of their pursuits of nearly 900 use cases, The Wall Street Journal (WSJ) reported Friday (April 18).Johnson & Johnson is now devoting resources to the highest-value projects and cutting the rest, according to the report.“We’re prioritizing, we’re scaling, we’re looking at the things that make the most sense,” Johnson & Johnson Chief Information Officer Jim Swanson said, per the report. “That was part of the maturation process we went through.”The use cases that are delivering the most value include a generative AI copilot that coaches sales representatives on how to engage with healthcare professionals, and an internal chatbot that answers employees’ questions about company policies and benefits, according to the report.Johnson & Johnson is also developing an AI tool that will facilitate drug discovery and another that will identify and mitigate supply chain risks, per the report.Swanson said in the report that the broader approach was necessary three years ago to gain familiarity with the technology but that it’s now time to focus on the use cases that can be successfully implemented, are widely adopted and deliver value.The PYMNTS Intelligence report “The AI MonitorEdge Report: Healthcare Firms Going Long on GenAI Investment” found that 90% of C-suite executives at healthcare firms with at least $1 billion in annual revenue said that their previous generative AI investments have already achieved a positive return on investment.The two applications that represent the most frequent use cases of generative AI — product and service innovation and real-time automated customer service responses — are being used by about 6 in 10 of these healthcare firms, per the report.It was reported in March that Apple is working on an AI agent that can dispense medical advice.Healthcare AI firm Suki said in October that it raised $70 million in new funding to invest in the development of its products, which include an AI-powered voice assistant used by clinicians.In October 2023, Microsoft unveiled AI-powered products that help doctors glean insights from medical data.For all PYMNTS AI coverage, subscribe to the daily AI Newsletter